![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 18, 2007 3:33:58 PM
Not necessarily. First the owner has to want to sell. And then a "value" is defined by how much the final agreed price is.
If there is a final price.
Hence sharestructure. Using the lack of a Merck buyout as some kind of reason to say that DNAPrint isn't worth it is
ignorant and shortsighted.
A lack of a buyout could actually mean the opposite. It could mean that DNAPrint values it's future enough to go out of the way to mmake sure it keeps 60 % of it's O.S. out of the hands of others. At any cost.
Bashing on supposition. Pumping on supposition.
What a zoo.
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM